The Edge
For the 300,000 Canadians living with Type 1 Diabetes, low blood sugar is a constant concern, and can even be deadly. Join Kate as she delves into the world of diabetic research to uncover a breakthrough drug that takes the fear out of ‘going low’. In this episode, Kate speaks to Michael Midmer, CEO at Zucara Therapeutics, Dr. Michael Riddell, leading diabetes expert and Chair of Zucara’s Scientific Advisory Board, and Dana Greenberg, who lives with Type 1 Diabetes.
3 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de The Edge!